Skip to main content
Top

Breast Cancer Research

Issue 1/2001

Content (20 Articles)

Commentary

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

Robert L Sutherland, Elizabeth A Musgrove

Open Access Research article

Comparison of various characteristics of women who do and do not attend for breast cancer screening

Emily Banks, Valerie Beral, Rebecca Cameron, Ann Hogg, Nicola Langley, Isobel Barnes, Diana Bull, Gillian Reeves, Ruth English, Sarah Taylor, Jon Elliman, Carole Lole Harris

Open Access Research article

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

Victoria M Basham, Julian M Lipscombe, Joanna M Ward, Simon A Gayther, Bruce AJ Ponder, Douglas F Easton, Paul DP Pharoah

Paper Report

Sequential tumour biopsies in phase I trials

Fatima Cardoso

Paper Report

Primary chemotherapy with CEF-infu

Fatima Cardoso

Paper Report

Gene expression profiling

Valerie Speirs

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine